S. Ya. Zhanayeva

S. Ya. Zhanayeva

Auto-generated profile, based on publicly available information

S. Ya. Zhanayeva

Institute of Physiology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
TAT. V. Alekseyenko
T. V. Alekseyenko
SZS. Ya. Zhanayeva
S. Ya. Zhanayeva
AVA. A. Venediktova
A. A. Venediktova
TZT. N. Zvyagintseva
T. N. Zvyagintseva
Tatyana KuznetsovaTatyana Kuznetsova
Tatyana Kuznetsova
Tatiana A. Alexandrovna KorolenkoTatiana A. Alexandrovna Korolenko
Tatiana A. Alexandrovna Korolenko

1 January 2020 in Yakut Medical Journal
Verified
Journal Article
Closed access
ASA.A. Shvaikovskaya
A.A. Shvaikovskaya
SZS.Y. Zhanaeva
S.Y. Zhanaeva
AEA.V. Evsyukova
A.V. Evsyukova
MTM.A. Tikhonova
M.A. Tikhonova
Konstantin V. DanilenkoKonstantin V. Danilenko
Konstantin V. Danilenko
LALyubomir Aftanas
Lyubomir Aftanas
Brain neurotrophic factor (BDNF) is one of the key indicators of neurogenesis and neuroplasticity. The concentration of BDNF in the blood is positioned as a potential biomarker of the development and dynamics of neuropsychiatric diseases. However, the extent to which its concentration in the blood reflects its content in the brain is not clear; a literature analysis on this matter has not been performed. This review provides basic information about the biological role, content and regulation of BDNF in the body (chapter I), about the concentration of BDNF in the blood in neuropsychiatric diseases (chapter II), and analyzes the correlation of BDNF content in the brain and blood (chapter III, the main one). In 5 out of 6 studies on intact animals identified as a result of the literature search, a statistically significant positive correlation between the concentration of BDNF in the brain and blood is reported. However, the correlation coefficient is variable and generally not high - from 0.40 to 0.83. There were no during-life studies performed in human. Some post-mortem studies have reported a significant association between BDNF indices values in the brain and in the periphery. Thus, the question of the extent to which BDNF in the blood is diagnostically valuable remains unanswered.

1 February 2005 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
SZS. Ya. Zhanaeva
S. Ya. Zhanaeva
Tatiana A. Alexandrovna KorolenkoTatiana A. Alexandrovna Korolenko
Tatiana A. Alexandrovna Korolenko
OKO. M. Khoshchenko
O. M. Khoshchenko
VSV. K. Spiridonov
V. K. Spiridonov
VNV. P. Nikolin
V. P. Nikolin
VKV. I. Kaledin
V. I. Kaledin

1 October 2005 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
SZS. Ya. Zhanaeva
S. Ya. Zhanaeva
Tatiana A. Alexandrovna KorolenkoTatiana A. Alexandrovna Korolenko
Tatiana A. Alexandrovna Korolenko
BNB. G. Nekrasov
B. G. Nekrasov
VNV. P. Nikolin
V. P. Nikolin
VKV. I. Kaledin
V. I. Kaledin

20 March 2009 in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
Verified
Journal Article
Closed access
PDF file
SZS. Ya. Zhanaeva
S. Ya. Zhanaeva
ADA. I. Dyakov
A. I. Dyakov
TAT. A. Alekseenko
T. A. Alekseenko
Tatiana A. Alexandrovna KorolenkoTatiana A. Alexandrovna Korolenko
Tatiana A. Alexandrovna Korolenko
The influence of the antitumor drugs, cyclophosphamide (CPA) and nitrosomethylurea (NMU) on the activity of lysosomal cysteine proteases cathepsin B and L in tumor tissue has been investigated using CPA-sensitive (LS) and CPA-resistant mouse lymphosarcomas (RLS). (These drugs exhibit high and low antitumor efficiency towards LS and RLS mouse lymphosarcomas, respectively). Regression or reduction in the growth rate of LS and RLS lymphosarcomas caused by CPA or NMU administration was accompanied by the increase in the activity of cysteine proteases cathepsin B and L in the tumor tissue. The increase of cathepsin B and L activity in tumor tissue correlated with the therapeutic effect of these drugs. Data obtained suggest that activity of cathepsin B and L in tumor tissue has a prognostic significance for the estimation of the effectiveness of antitumor therapy.